Candel Therapeutics Inc (NASDAQ: CADL) open the trading on Thursday, with great promise as it jumped 11.55% to $6.47, before settling in for the price of $5.8 at the close. Taking a more long-term approach, CADL posted a 52-week range of $4.25-$14.60.
It was noted that the giant of the Healthcare sector posted annual sales growth of -43.86% over the last 5 years. Meanwhile, its Annual Earning per share during the time was -43.86%. Nevertheless, stock’s Earnings Per Share (EPS) this year is 76.06%. This publicly-traded company’s shares outstanding now amounts to $54.90 million, simultaneously with a float of $41.06 million. The organization now has a market capitalization sitting at $355.19 million. At the time of writing, stock’s 50-day Moving Average stood at $5.26, while the 200-day Moving Average is $5.71.
Candel Therapeutics Inc (CADL) Ownership Facts and Figures
Sometimes it helps to make our mind if we keep our tabs on how bigger investors are working with the stock of the Biotechnology industry. Candel Therapeutics Inc’s current insider ownership accounts for 25.21%, in contrast to 36.98% institutional ownership. According to the most recent insider trade that took place on Jul 28 ’25, this organization’s Chief Medical Officer sold 937 shares at the rate of 6.98, making the entire transaction reach 6,540 in total value, affecting insider ownership by 52,493. Preceding that transaction, on Jun 30 ’25, Company’s Chief Medical Officer sold 781 for 5.04, making the whole transaction’s value amount to 3,936. This particular insider is now the holder of 52,493 in total.
Candel Therapeutics Inc (CADL) Earnings and Revenue Records
Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.21 per share during the current fiscal year.
Candel Therapeutics Inc’s EPS increase for this current 12-month fiscal period is 76.06% and is forecasted to reach -0.99 in the upcoming year. Considering the longer run, market analysts have predicted that Company’s EPS will increase by 35.44% through the next 5 years, which can be compared against the -43.86% growth it accomplished over the previous five years trading on the market.
Candel Therapeutics Inc (NASDAQ: CADL) Trading Performance Indicators
Let’s observe the current performance indicators for Candel Therapeutics Inc (CADL). It’s Quick Ratio in the last reported quarter now stands at 8.25.
In the same vein, CADL’s Diluted EPS (Earnings per Share) trailing twelve months is recorded -0.56, a figure that is expected to reach -0.25 in the next quarter, and analysts are predicting that it will be -0.99 at the market close of one year from today.
Technical Analysis of Candel Therapeutics Inc (CADL)
[Candel Therapeutics Inc, CADL] recent stats showed that its last 5-days Average volume was superior the volume it posted in the year-ago period. During the previous 9 days, stock’s Stochastic %D was recorded 89.51% While, its Average True Range was 84.43.
Raw Stochastic average of Candel Therapeutics Inc (CADL) in the period of the previous 100 days is set at 74.13%, which indicates a major fall in contrast to 85.66% during the last 2-weeks. If we go through the volatility metrics of the stock, In the past 14-days, Company’s historic volatility was 0.35 that was higher than 0.33 volatility it exhibited in the past 100-days period.
